http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03106969-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
filingDate | 2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c924f6ea2c36f1910a7787678a540de9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac6ce4f9371e9ce9942e527a7e5bea0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b734ac3ea960ddfe0c951d22bb1800cd |
publicationDate | 2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-03106969-A2 |
titleOfInvention | Ribonuclease zymogen design |
abstract | An enzyme is re-engineered to be a zymogen, an enzyme precursor which is converted into an enzyme by protease cleavage. In the example described here, an RNase A enzyme is converted into a zymogen by adding to the enzyme a bridge of amino acids linking the amino and carboxyl termini of the enzyme. The bridge has built in it a protease cleavage site for a specific protease, for example the protease plasmepsin II, produced by the malaria parasite. Since RNase A can be made cytotoxic, this permits a cytotoxic enzyme to be made in the form of a zymogen that becomes active only when it is acted on by a protease only present in a particular target cell such as a pathogen. |
priorityDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.